Trident Lifeline IPO is engaged in the marketing of pharmaceutical products in domestic as well as international market. The company is also engaged in distribution of pharmaceutical products through third-party distribution network.
Trident Lifeline IPO – Overview
| IPO Dates | 26-29 sept 2022. |
| IPO Price | INR 101 per share |
| Fresh issue | 3,499,200 shares (INR 35.34 crore) |
| Offer For Sale | Nil |
| Total IPO size | 3,499,200 shares (INR 35.34 crore) |
| Minimum bid (lot size) | 1200 shares |
| Face Value | INR 10 per share |
| Retail Allocation | 50% |
| Listing On | BSE Emerge |
Trident Lifeline IPO -Tentative Dates
| IPO Offer Opening Date | 26 September 2022 |
| IPO Closing Date | 29 September 2022 |
| Finalisation of Basis of Allotment | 4 October 2022 |
| Initiation of refunds | 6 October 2022 |
| Transfer of shares to demat accounts | 7 October 2022 |
| IPO Listing Date | 10 October 2022 |
| Opening Price on BSE SME | Coming soon |
| Closing Price on BSE SME | Coming soon |
Company Overview
Incorporated in 2014, Trident Lifeline Limited is engaged in the marketing of pharmaceutical products in domestic as well as international market. The company is also engaged in distribution of pharmaceutical products through third-party distribution network.
Trident Lifeline Limited offers a wide range of pharmaceutical formulations and products manufactured on contract manufacturing under a loan license.
Trident Lifeline product portfolio consists of 832 products, as on May 31, 2022, including Anti-Bacterial, Anti Diarrheal, Anti-Fungal, Anti-Malarial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical and Non-steroidal anti-inflammatory drug (NSAIDs).
Trident Lifeline core business categories:
1. Ethical marketing of pharmaceutical formulation & products in the International Market through a third-party distribution network and sales force under its brand.
2. Getting the approved formulations manufactured through Contract Manufacturers, Source & Supply of Generic Pharma formulation and medicines in Domestic as well as International Market.
The company operate in India as well as African, Latin American and East Indian Countries. The company have a presence through registered products or products under registration in countries like Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanmar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, and Venezuela.
Objects of the Issue
- Funding additional Working capital requirements
- General Corporate Purposes
Company Financials
| Particulars | 31-March-22 | 31-June-21 | 31-Mar-20 |
| Total Assets | 1385.98 | 1144.41 | 638.92 |
| Total Revenue | 2237.14 | 978.13 | 500.71 |
| Profit After Tax | 227.32 | 63.23 | -79.63 |
Company Contact Information
Trident Lifeline Limited
2nd Floor, Shop-2004,
North Extension, Falsawadi Begumpura, Nodh-4/1650,
Sahara Darwaja, Surat – 395003
Phone: 8160276395
Email: compliance@tridentlifeline.com
Website: http://www.tridentlifeline.com/
Registrar
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: trilife.ipo@linkintime.co.in
Website: https://linkintime.co.in/
Lead Manager(s)
- Beeline Capital Advisors Pvt Ltd (Past IPO Performance)
Lead Manager Reports
- IPO Lead Manager Performance Summary
- IPO Lead Manager Performance Tracker
